Intermittent Exotropia and Overminus Lens Therapy in Macedonia

Antonela Ljubic; Galina Dimitrova; Snezhana Zechevikj; Vladimir Trajkovski

doi:10.3889/oamjms.2024.11950

Authors

Antonela Ljubic Department of Ophthalmology, Private Polyclinic Medika Plus, Skopje, Republic of North Macedonia https://orcid.org/0000-0002-4221-0124
Galina Dimitrova Department of Ophthalmology, City General Hospital “September 8 “, Skopje, Republic of North Macedonia; Department of Ophthalmology, Faculty of Dental Medicine, European University, Skopje, Republic of North Macedonia https://orcid.org/0000-0003-3537-4363
Snezhana Zechevikj Department of Strabismus and Amblyopia, European Eye Hospital, Skopje, Republic of North Macedonia; Department of Ophthalmology, Faculty of Medical Sciences, University “Goce Delchev”, Shtip, Republic of North Macedonia https://orcid.org/0000-0001-8577-4889
Vladimir Trajkovski Institute of Special Education and Rehabilitation, Faculty of Philosphy , Ss. Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia https://orcid.org/0000-0002-8369-9501

DOI:

https://doi.org/10.3889/oamjms.2024.11950

Keywords:

Exotropia, intermittent exotropia, overminus lens therapy, office based control score (Mayo)

Abstract

AIM: Intermittent exotropia (IXT) is the most common form of exodeviations. The aim of our study was to investigate the outcome after overminus lens therapy in children and young adults with IXT.

METHODS: Fifty-three children and young adults with IXT, aged 3–33 years, from Macedonia, underwent slit-lamp examination, ocular motility, and refraction. For assessing near control in children and young adults with IXT, we used an office-based Mayo Scale.

RESULTS: Most of the patients had Mayo score 1 (30.2%) and Mayo score 2 (26.4%). A Mayo score of 3 was presented in 18.9% of the patients, and Mayo score of 0 in 15.1%. A Mayo score of 4 was presented in 5.7%, and Mayo scored only in 3.8% of the IXT patients. After prescribing overminus glasses, 43.4% of the IXT patients showed better outcomes with better punctum proximum convergence and/or, better stereoacuity, and/or smaller near angle of deviation (in pdp). 52.8% same motility and sensory outcome was observed, whereas only in 3.8% worse findings were reported.

CONCLUSIONS: Our study group was with a mean age over 5 (10.2 years) and we used lower overminus therapy (add. −0.75 D). The following studies of overminus lens therapy on IXT children and young adults over 5 years of age, should confirm our findings of a high percentage of improvement in terms of Mayo near control assessment.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Graham PA. Epidemiology of strabismus. Br J Ophthalmol.1974;58(3):224-31. https://doi.org/10.1136/bjo.58.3.224 PMid:4834596 DOI: https://doi.org/10.1136/bjo.58.3.224

Lang J. Strabismus: Diagnostik-Schielformen-Therapie. Bern, Switzerland: Hans Huber; 1955.

Cooper J, Medlow N. Intermittent exotropia. Basic and divergence excess type. Binoc Vis. 1993;8(3):185-216.

Yu CB, Fan DS, Wong VW, Wong CY, Lam DS. Changing patterns of strabismus: A decade of experience in Hong Kong. Br J Ophthalmol. 2002;86(8):854-6. https://doi.org/10.1136/bjo.86.8.854 PMid:12140202 DOI: https://doi.org/10.1136/bjo.86.8.854

Ing MR, Pang SW. The racial distribution of strabismus. In: Reinecke RD, editor. Strabismus. 2nd ed. New York: Grune and Strattom; 1978.

Govindan M, Mohney BG, Diehl MN, Burke JP. Incidence and types of childhood exotropia: A population-based study. Ophthalmology. 2005;112(1):104-8. https://doi.org/10.1016/j.ophtha.2004.07.033 PMid:15629828 DOI: https://doi.org/10.1016/j.ophtha.2004.07.033

Wright KW, Strube YN. Color Atlas of Strabismus Surgery: Strategies and Techniques. 4th ed. New York: Springer Science + Bussiness Media; 2015. DOI: https://doi.org/10.1007/978-1-4939-1480-7

Ljubic A. Intermittent exotropia (IXT). Vox Med. 2015;23:334-6.

Mohney BG, Huffaker RK. Common forms of childhood exotropia. Ophthalmology. 2003;110(11):2093-6. https://doi.org/10.1016/j.ophtha.2003.04.001 PMid:14597514 DOI: https://doi.org/10.1016/j.ophtha.2003.04.001

Rowe FJ, Noonan CP, Freeman G, De Bell J. Intervention for intermittent distance exotropia with overcorrecting minus lenses. Eye. 2009;23(2):320-5. https://doi.org/10.1038/sj.eye.6703057 PMid:18064054 DOI: https://doi.org/10.1038/sj.eye.6703057

Mohney BG, Holms JM. An office-based scale for assessing control in intermittent exotropia. Strabismus. 2006;14(3):147- 50. https://doi.org/10.1080/09273970600894716 PMid:16950743 DOI: https://doi.org/10.1080/09273970600894716

Pediatric Eye Disease Investigator Group, Chen AM, Holmes JM, Chandler DL, Patel RA, Gray ME, et al. A randomized trial evaluating short-term effectiveness of overminus lenses in children 3 to 6 years of age with intermittent exotropia. Ophthalmology. 2016;123(10):2127-36. https://doi.org/10.1016/j.ophtha.2016.06.042 PMid:27506485 DOI: https://doi.org/10.1016/j.ophtha.2016.06.042

Bayramal H, Gurturk AY, Sari U, Karadag R. Overcorrecting minus lens therapy in patients with intermittent exotropia: Should it be the first therapeutic choise? Int Ophthalmol. 2017;37(2):385-90. https://doi.org/10.1007/s10792-016-0273-9 PMid:27259481 DOI: https://doi.org/10.1007/s10792-016-0273-9

Watts P, Tippings F, Al-Madafai H. Intermittent exotropia, overcorrecting minus lenses, and the Newcastle scoring system. JAAPOS. 2005;9(5):460-4. https://doi.org/10.1016/j.jaapos.2005.04.010 PMid:16213396 DOI: https://doi.org/10.1016/j.jaapos.2005.04.010

Agdham AK, Zand A, Sanjari MS, Khorramdel S, Asadi R. Overminus lens therapy in the management of children with intermittent exotropia. J Curr Ophthalmol. 2021;33(1):36-40. https://doi.org/10.4103/JOCO.JOCO_17_20 PMid:34084955 DOI: https://doi.org/10.4103/JOCO.JOCO_17_20

Pediatric Eye Disease Investigator Group, Chen A, Erzurum A, Chandler DL, Hercinovic A, Michele Melia B, Bhatt AR, et al. Overminus lens therapy for children 3 to 10 years of age with Intermittent exotropia: A randomized clinical trial. JAMA Ophthalmol. 2021;139(4):464-76. https://doi.org/10.1001/jamaophthalmol.2021.0082 PMid:33662112 DOI: https://doi.org/10.1001/jamaophthalmol.2021.0082